{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:22:03Z","timestamp":1793312523677,"version":"4.5.0"},"reference-count":33,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institutes of Health","award":["CA-175691"],"award-info":[{"award-number":["CA-175691"]}]},{"name":"National Institutes of Health","award":["CA-006927"],"award-info":[{"award-number":["CA-006927"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: BAP1 mutation carriers are predisposed to the development of mesothelioma. In mice, there is limited data and controversy about whether germline Bap1 heterozygous mutations alone cause mesothelioma. However, a marked increase in mesothelioma incidence is observed in Bap1-mutant mice upon even minimal asbestos exposures. Methods: To address this issue, we investigated spontaneous mesothelioma development over the lifetime of a large cohort of Bap1-mutant and wild-type (WT) mice across several genetic backgrounds. To determine if the incidence of mesotheliomas in Bap1-mutant mice is significantly increased compared to WT mice, we performed statistical analyses using frequentist and Bayesian frameworks. In the Bayesian framework, to model the probability of disease occurrence, a non-informative prior was used for Bap1-mutant mice, whereas an informative prior for the WT group was derived from historical data spanning the animals\u2019 lifetimes. Multiple strategies were employed to incorporate historical data and infer the informative prior, including a meta-analysis, assuming a consistent probability of mesothelioma across historical datasets, and applying Bayesian meta-analytic predictive priors derived from historical data. Posterior distribution was used, and a comparison was made using odds ratio, risk difference, and risk ratio. Results: Spontaneous mesotheliomas were detected in 2\/329 Bap1-mutant and 0\/227 WT mice from various genetic backgrounds. Using four statistical approaches, the results did not detect a significant difference in the probabilities of mesothelioma occurrence between Bap1-mutant and WT mice.\u00a0 Conclusions: Based on these analyses, we cannot conclude that germline Bap1-mutant mice have a significantly increased risk of mesothelioma in the absence of asbestos exposure.<\/jats:p>","DOI":"10.3390\/cancers17162692","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T10:59:01Z","timestamp":1755601141000},"page":"2692","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Spontaneous Mesotheliomas in Germline Bap1 Heterozygous Mice from Different Genetic Backgrounds"],"prefix":"10.3390","volume":"17","author":[{"given":"Yuwaraj","family":"Kadariya","sequence":"first","affiliation":[{"name":"Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[{"name":"Biostatistics and Bioinformatics Facility, Fox Chase Cancer Center, Philadelphia, PA 19111, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Sementino","sequence":"additional","affiliation":[{"name":"Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Ross","sequence":"additional","affiliation":[{"name":"Biostatistics and Bioinformatics Facility, Fox Chase Cancer Center, Philadelphia, PA 19111, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1301-5175","authenticated-orcid":false,"given":"Joseph R.","family":"Testa","sequence":"additional","affiliation":[{"name":"Cancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"key":"ref_1","unstructured":"Adam, M.P., Ardinger, H.H., Pagon, R.A., Wallace, S.E., Bean, L.J.H., Mefford, H.C., Stephens, K., Amemiya, A., and Ledbetter, N. (2016). BAP1 Tumor Predisposition Syndrome. GeneReviews(R), University of Washington. [Internet]."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/jnci\/djy171","article-title":"Comprehensive study of the clinical phenotype of germline BAP1 variant-carrying families worldwide","volume":"110","author":"Walpole","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1158\/0008-5472.CAN-14-1328","article-title":"Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma","volume":"74","author":"Xu","year":"2014","journal-title":"Cancer Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1038\/onc.2015.243","article-title":"Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma","volume":"35","author":"Napolitano","year":"2016","journal-title":"Oncogene"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1158\/0008-5472.CAN-15-3371","article-title":"Bap1 is a bona fide tumor suppressor: Genetic evidence from mouse models carrying heterozygous germline Bap1 mutations","volume":"76","author":"Kadariya","year":"2016","journal-title":"Cancer Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1158\/2767-9764.CRC-23-0423","article-title":"Low exposures to amphibole or serpentine asbestos in germline Bap1-mutant mice induce mesothelioma characterized by an immunosuppressive tumor microenvironment","volume":"4","author":"Kadariya","year":"2024","journal-title":"Cancer Res. Commun."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","author":"Testa","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e70086","DOI":"10.1002\/cpz1.70086","article-title":"Modeling malignant mesothelioma in genetically engineered mice","volume":"5","author":"Kadariya","year":"2025","journal-title":"Curr. Protoc."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1126\/science.1221711","article-title":"Loss of the tumor suppressor BAP1 causes myeloid transformation","volume":"337","author":"Dey","year":"2012","journal-title":"Science"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Gelman, A., Carlin, J.B., Stern, H.S., Dunson, D.B., Vehtari, A., and Rubin, D.B. (2014). Bayesian Data Analysis, Chapman and Hall\/CRC Press. [3rd ed.].","DOI":"10.1201\/b16018"},{"key":"ref_11","first-page":"272","article-title":"Essential standards of biometrical sample size calculation for animal experiments in preclinical research in terms of the 3R","volume":"131","author":"Mayer","year":"2018","journal-title":"Berl. Munch. Tierarztl. Wochenschr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/jrsm.1475","article-title":"On weakly informative prior distributions for the heterogeneity parameter in Bayesian random-effects meta-analysis","volume":"12","author":"Rover","year":"2021","journal-title":"Res. Synth. Methods"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jrsm.12","article-title":"A basic introduction to fixed-effect and random-effects models for meta-analysis","volume":"1","author":"Borenstein","year":"2010","journal-title":"Res. Synth. Methods"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1002\/sim.4040","article-title":"Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data","volume":"29","author":"Stijnen","year":"2010","journal-title":"Stat. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin. Trials"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1740774509356002","article-title":"Summarizing historical information on controls in clinical trials","volume":"7","author":"Neuenschwander","year":"2010","journal-title":"Clin. Trials"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/biom.12242","article-title":"Robust meta-analytic-predictive priors in clinical trials with historical control information","volume":"70","author":"Schmidli","year":"2014","journal-title":"Biometrics"},{"key":"ref_18","unstructured":"Team, S.D. (2025, June 11). RStan: The R interface to Stan. Available online: https:\/\/mc-stan.org\/rstan\/."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Nielsen, D.M., Hsu, M., Zapata, M., Ciavarra, G., and van Zyl, L. (2025). Bayesian analysis of the rate of spontaneous malignant mesothelioma among BAP1 mutant mice in the absence of asbestos exposure. Sci. Rep., 15.","DOI":"10.1038\/s41598-024-84069-w"},{"key":"ref_20","first-page":"253","article-title":"Histopathologic findings and establishment of novel tumor lines from spontaneous tumors in FVB\/N mice","volume":"58","author":"Huang","year":"2008","journal-title":"Comp. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10522-015-9611-y","article-title":"Biomarkers of aging, life span and spontaneous carcinogenesis in the wild type and HER-2 transgenic FVB\/N female mice","volume":"17","author":"Panchenko","year":"2016","journal-title":"Biogerontology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1186\/s12967-023-04614-5","article-title":"Preventive and therapeutic opportunities: Targeting BAP1 and\/or HMGB1 pathways to diminish the burden of mesothelioma","volume":"21","author":"Carbone","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/10408448409003374","article-title":"Factors affecting spontaneous tumor incidence rates in mice: A literature review","volume":"13","author":"Everett","year":"1984","journal-title":"Crit. Rev. Toxicol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Zhou, Y., Xia, J., Xu, S., She, T., Zhang, Y., Sun, Y., Wen, M., Jiang, T., Xiong, Y., and Lei, J. (2023). Experimental mouse models for translational human cancer research. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1095388"},{"key":"ref_25","unstructured":"Giknis, M.L.A., and Clifford, C.B. (2005). Spontaneous Neoplastic Lesions in the CrI:CD-1(ICR) Mouse in Control Groups from 18 Month to 2 Year Studies, Charles River Laboratories."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/019262338801600305","article-title":"Mortality, major cause of moribundity, and spontaneous tumors in CD-1 mice","volume":"16","author":"Maita","year":"1988","journal-title":"Toxicol. Pathol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/gcc.22670","article-title":"Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes","volume":"57","author":"Betti","year":"2018","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejca.2021.12.023","article-title":"Malignant pleural mesothelioma: Germline variants in DNA repair genes may steer tailored treatment","volume":"163","author":"Sculco","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2018.78.5204","article-title":"Frequency of germline mutations in cancer susceptibility genes in malignant mesothelioma","volume":"36","author":"Panou","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"9008","DOI":"10.1073\/pnas.1821510116","article-title":"Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy","volume":"116","author":"Hassan","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1158\/2159-8290.CD-19-1220","article-title":"Biological mechanisms and clinical significance of BAP1 mutations in human cancer","volume":"10","author":"Carbone","year":"2020","journal-title":"Cancer Discov."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41467-017-02428-w","article-title":"Punctuated evolution of canonical genomic aberrations in uveal melanoma","volume":"9","author":"Field","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"a004051","DOI":"10.1101\/mcs.a004051","article-title":"Genomic evolution of uveal melanoma arising in ocular melanocytosis","volume":"5","author":"Durante","year":"2019","journal-title":"Cold Spring Harb. Mol. Case Stud."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/16\/2692\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:30:38Z","timestamp":1760034638000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/16\/2692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":33,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["cancers17162692"],"URL":"https:\/\/doi.org\/10.3390\/cancers17162692","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,19]]}}}